FIGURE

Fig. 3.

ID
ZDB-FIG-260602-69
Publication
Lai et al., 2026 - A novel zebrafish luminescent biosensor for kidney tubulopathy, metal toxicity, and drug screening
Other Figures
All Figure Page
Back to All Figure Page
Fig. 3.

Bioluminescent vdbp-NanoLuc reporter to detect drug nephrotoxicity. (A) Experimental protocol used in gentamicin nephrotoxicity assessment and its rescue by taurine co-treatment using transgenic zebrafish larvae. TEM, transmission electron microscopy. (B) Microscopic examination of 4 dpf gentamicin-treated Tg(PiT1::ctns-EGFP) zebrafish larvae expressing lysosomal marker Ctns-EGFP in PT cells using multiphoton fluorescence microscopy (top). Accumulation of Ctns-EGFP-positive vesicles is observed in PT cells of gentamicin-treated transgenic zebrafish larvae. Dashed lines outline the proximal tubule. PT, proximal tubule. Relative EGFP fluorescence intensity (bottom left) and EGFP-positive vesicle number (bottom right) are quantified for each proximal tubule. n=13 (vehicle), n=11 (gentamicin). Scale bars: 30 µm. (C) Ultrastructure of pronephros in 4 dpf larvae treated with gentamicin or vehicle analyzed by transmission electron microscopy. Accumulation of electron-dense vesicles in PT epithelial cells reflects lysosomal phospholipidosis. n=5. Yellow dashed line squares contain images at higher magnification. BB, brush border. Scale bars: 5 µm (left column), 1 µm (right column). (D) Urine samples were obtained at 2 days post-injection from ½vdbp-NanoLuc larvae treated with vehicle, gentamicin alone or gentamicin/taurine and analyzed by luminometry. The variation observed in the gentamicin-injected group may be due to technical limitations of intravenous injection. n=28 (vehicle), n=26 (gentamicin) and n=28 (gentamicin/taurine). (E) Larval lethality in 4 dpf larvae treated with vehicle, cisplatin (0.5 mM or 1 mM) alone or co-incubated with cisplatin (0.5 mM or 1 mM)+10 mM sodium thiosulfate (STS) for 24 h. Treatment with 1 mM cisplatin for 24 h is lethal for zebrafish larvae but rescued by co-treatment with 10 mM STS. n=40. (F) Morphological examination of 4 dpf larvae treated with vehicle, 0.5 mM cisplatin alone or co-treatment of cisplatin (0.5 mM or 1 mM)+10 mM STS (left) and semi-quantitative scoring of inflation defects of swim bladder (right). n=40. Scale bars: 0.5 mm. (G) Behavioral analysis of 5 dpf zebrafish larvae incubated with vehicle, 0.5 mM cisplatin alone, or co-incubated with cisplatin (0.5 mM or 1 mM)+10 mM STS by movement tracking using the Zebrabox. n=40 (vehicle), n=31 (cisplatin alone), n=40 (0.5 mM cisplatin+10 mM STS), n=38 (1 mM cisplatin+10 mM STS). (H) Overnight urine was collected from 5 dpf ½vdbp-NanoLuc zebrafish larvae treated with vehicle, 0.5 mM cisplatin alone or co-incubated with cisplatin (0.5 mM or 1 mM)+10 mM STS for 24 h and analyzed by luminometry. n=39 (vehicle), n=31 (0.5 mM cisplatin alone), n=39 (0.5 mM cisplatin+10 mM STS), n=37 (1 mM cisplatin+10 mM STS). Plotted data represent mean±s.e.m. Nonparametric Mann–Whitney test, **P<0.01 ***P<0.001. NS, non-significant.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Conditions:
Observed In:
Stage Range: Long-pec to Day 5

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dis. Model. Mech.